⚖️ Switch or Stay? DOACs vs Warfarin in Frail AF Patients

🧓💊 The COMBINE-AF substudy offers important guidance for managing frail, elderly, VKA-experienced patients with atrial fibrillation. Switching to standard-dose DOACs reduced stroke/systemic embolism risk and cut intracranial & fatal bleeding 🧠🛡️, but raised gastrointestinal bleeding rates 🍽️🩸—especially with certain agents. Sensitivity analyses show apixaban & edoxaban may offer a safer bleeding profile. These findings highlight the need for shared decision-making ⚖️ and integrated ABC pathway care ❤️ to balance prevention, safety, and patient preferences. #AFib #Cardiology #PrecisionMedicine